Slowly but surely, the health benefits of medicinal mushrooms have been gaining traction across the globe as companies in the space invest time and money into the research and development of fungi.
Already, it has been shown that mushrooms have a range of benefits thanks to their rich sources of amino acids, proteins and vitamins. As such, medicinal mushrooms have been used to treat help alleviate common colds, seasonal allergies, asthma, inflammation, depression, anxiety, and even cancer.
Moving forward,
it is expected that the medicinal mushroom market will grow at a compound annual growth rate of 6.1 per cent to reach US$15.3 billion by 2026. Contributing to that market growth will be the increased awareness of the health benefits attributed to mushrooms. Additionally, companies in the space
will continue shifting their focus of these benefits into research and development efforts of medicinal mushrooms.
Companies like
The Good Shroom Co Inc. (TSXV:MUSH) are looking to be a part of that surge as the medicinal mushrooms sector is no doubt poised for unprecedented growth.
Meet The Good Shroom Company
Based out of Montreal, Quebec, The Good Shroom Company is
one of the latest companies to go public in the psychedelics sector.
The Good Shroom Company officially went public on the TSX Venture Exchange on April 28. Previously known as Cluny Capital Corp., The Good Shroom Company completed a qualifying transaction that involved fusing Teonan Biomedical with the company’s wholly-owned subsidiary as part of a three-way amalgamation between the companies.
Outstanding shares of Cluny Capital, a former publicly traded company, were consolidated on a 3 for 1 basis and effectively changed its name to The Good Shroom Company.
At its core, The Good Shroom Company aims to promote mushrooms to be used for physical, mental and spiritual wellbeing. The company believes the fungi contains multiple healing benefits.
In tandem with the company’s beliefs, The Good Shroom Company is focused on developing its brand of premium functional mushroom beverages and currently has two operative beverage brands under its belt: Teonan and Velada. The mushroom formula for the company’s beverages is developed with concentrated dual-extracts from the six mushroom species fruiting bodies that have been scientifically proven as being safe and effective for immune support and other health-related benefits.
Inside the company’s beverage brands
Now that The Good Shroom Company has its TSX Venture listing, the company is continuing to ramp up its efforts on its two beverage brands.
(
Click to enlarge image)
Teonan was first launched in December 2019, while the company anticipates launching a retail strategy of the beverage sometime in 2021.
The beverage comes in seven different flavours and has been sold to over 12,000 online clients throughout North America to date. Flavours include rooibos, ginger, coffee, coffee coconut, cacao, matcha and turmeric. Equally important is the fact that the beverages have the benefits of functional mushrooms without the mushroom taste.
Meanwhile Velada yields four of the Teonan flavours, but with at least 30 mg of cannabidoil (CBD). The company aims to have tetrahydrocannabinol (THC) version of the beverage sometime this year, pending final approval from regulatory bodies.
Investor potential
While the company is a newly publicly traded outfit, the potential of The Good Shroom Company is unparalleled.
As the health benefits of mushrooms continue to gain notoriety, so too will the legitimacy of the medicinal mushroom space.
Companies like The Good Shroom Company are helping to pave the way as a leader in the conscious commerce revolution. Additionally, The Good Shroom Company aims to prove that companies like itself are a force of regeneration and commercial success.
Following the company’s public listing, The Good Shroom Company expects that will have distribution deals for its mushroom products, which will be announced sometime this year.
In short, the medicinal mushrooms industry is poised for significant growth in the coming years, and The Good Shroom Company is one such company investors won’t want to miss out on.
To learn more, visit
www.thegoodshroom.co.
FULL DISCLOSURE: This is a paid article produced by Stockhouse Publishing.